156 related articles for article (PubMed ID: 25525927)
1. Bladder cancer screening in aluminum smelter workers.
Taiwo OA; Slade MD; Cantley LF; Tessier-Sherman B; Galusha D; Kirsche SR; Donoghue AM; Cullen MR
J Occup Environ Med; 2015 Apr; 57(4):421-7. PubMed ID: 25525927
[TBL] [Abstract][Full Text] [Related]
2. The value of the ImmunoCyt/uCyt+ test in the detection and follow-up of carcinoma in situ of the urinary bladder.
Mian C; Lodde M; Comploj E; Palermo S; Mian M; Maier K; Pycha A
Anticancer Res; 2005; 25(5):3641-4. PubMed ID: 16101194
[TBL] [Abstract][Full Text] [Related]
3. Mortality and cancer morbidity in workers from an aluminium smelter with prebaked carbon anodes--Part II: Cancer morbidity.
Rønneberg A; Andersen A
Occup Environ Med; 1995 Apr; 52(4):250-4. PubMed ID: 7795740
[TBL] [Abstract][Full Text] [Related]
4. uCyt+/ImmunoCyt and cytology in the detection of urothelial carcinoma: an update on 7422 analyses.
Comploj E; Mian C; Ambrosini-Spaltro A; Dechet C; Palermo S; Trenti E; Lodde M; Horninger W; Pycha A
Cancer Cytopathol; 2013 Jul; 121(7):392-7. PubMed ID: 23495066
[TBL] [Abstract][Full Text] [Related]
5. Bladder cancer screening among primary aluminum production workers in Quebec.
Thériault GP; Tremblay CG; Armstrong BG
J Occup Med; 1990 Sep; 32(9):869-72. PubMed ID: 2074510
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the presence of amino and nitro polycyclic aromatic hydrocarbons in a Söderberg primary aluminum smelter.
Farant JP; Ogilvie D
AIHA J (Fairfax, Va); 2002; 63(6):721-5. PubMed ID: 12570080
[TBL] [Abstract][Full Text] [Related]
7. Combinations of urine-based tumour markers in bladder cancer surveillance.
Horstmann M; Patschan O; Hennenlotter J; Senger E; Feil G; Stenzl A
Scand J Urol Nephrol; 2009; 43(6):461-6. PubMed ID: 19903092
[TBL] [Abstract][Full Text] [Related]
8. Early results of urothelial carcinoma screening in a risk population of coke workers: urothelial carcinoma among coke workers.
Giberti C; Gallo F; Schenone M; Genova A
Biomed Environ Sci; 2010 Aug; 23(4):300-4. PubMed ID: 20934118
[TBL] [Abstract][Full Text] [Related]
9. uCyt+ test: alternative to cystoscopy for less-invasive follow-up of patients with low risk of urothelial carcinoma.
Lodde M; Mian C; Comploj E; Palermo S; Longhi E; Marberger M; Pycha A
Urology; 2006 May; 67(5):950-4. PubMed ID: 16698355
[TBL] [Abstract][Full Text] [Related]
10. Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison.
Hautmann S; Toma M; Lorenzo Gomez MF; Friedrich MG; Jaekel T; Michl U; Schroeder GL; Huland H; Juenemann KP; Lokeshwar VB
Eur Urol; 2004 Oct; 46(4):466-71. PubMed ID: 15363562
[TBL] [Abstract][Full Text] [Related]
11. Estimation of risk of developing bladder cancer among workers exposed to coal tar pitch volatiles in the primary aluminum industry.
Tremblay C; Armstrong B; Thériault G; Brodeur J
Am J Ind Med; 1995 Mar; 27(3):335-48. PubMed ID: 7747740
[TBL] [Abstract][Full Text] [Related]
12. uCyt+/ImmunoCyt in the detection of recurrent urothelial carcinoma: an update on 1991 analyses.
Mian C; Maier K; Comploj E; Lodde M; Berner L; Lusuardi L; Palermo S; Vittadello F; Pycha A
Cancer; 2006 Feb; 108(1):60-5. PubMed ID: 16411183
[TBL] [Abstract][Full Text] [Related]
13. Lung cancer mortality in aluminum reduction plant workers.
Gibbs GW; Horowitz I
J Occup Med; 1979 May; 21(5):347-53. PubMed ID: 469596
[TBL] [Abstract][Full Text] [Related]
14. Cancer risk among workers of a secondary aluminium smelter.
Maltseva A; Serra C; Kogevinas M
Occup Med (Lond); 2016 Jul; 66(5):412-4. PubMed ID: 27170736
[TBL] [Abstract][Full Text] [Related]
15. The role of haematuria in bladder cancer screening among men with former occupational exposure to aromatic amines.
Pesch B; Nasterlack M; Eberle F; Bonberg N; Taeger D; Leng G; Feil G; Johnen G; Ickstadt K; Kluckert M; Wellhäusser H; Stenzl A; Brüning T;
BJU Int; 2011 Aug; 108(4):546-52. PubMed ID: 21223477
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up study of mortality and the incidence of cancer in a cohort of workers at a primary aluminum smelter in Sweden.
Björ O; Damber L; Edström C; Nilsson T
Scand J Work Environ Health; 2008 Dec; 34(6):463-70. PubMed ID: 19137208
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
Blick CG; Nazir SA; Mallett S; Turney BW; Onwu NN; Roberts IS; Crew JP; Cowan NC
BJU Int; 2012 Jul; 110(1):84-94. PubMed ID: 22122739
[TBL] [Abstract][Full Text] [Related]
18. Mortality and cancer experience of Quebec aluminum reduction plant workers. Part I: The reduction plants and coal tar pitch volatile (CTPV) exposure assessment.
Lavoué J; Gérin M; Côté J; Lapointe R
J Occup Environ Med; 2007 Sep; 49(9):997-1008. PubMed ID: 17848856
[TBL] [Abstract][Full Text] [Related]
19. Mortality and cancer incidence in aluminum reduction plant workers.
Spinelli JJ; Band PR; Svirchev LM; Gallagher RP
J Occup Med; 1991 Nov; 33(11):1150-5. PubMed ID: 1765856
[TBL] [Abstract][Full Text] [Related]
20. Genetic monitoring of aluminum workers exposed to coal tar pitch volatiles.
Heussner JC; Ward JB; Legator MS
Mutat Res; 1985 Mar; 155(3):143-55. PubMed ID: 3974629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
